Literature DB >> 21855656

Pathogenesis of Takayasu's arteritis: a 2011 update.

Laurent Arnaud1, Julien Haroche, Alexis Mathian, Guy Gorochov, Zahir Amoura.   

Abstract

While our knowledge of the pathogenesis of Takayasu's arteritis (TA) has considerably improved during the last decade, the exact pathogenic sequence remains to be elucidated. It is now hypothesised that an unknown stimulus triggers the expression of the 65kDa Heat-shock protein in the aortic tissue which, in turn, induces the Major Histocompatibility Class I Chain-Related A (MICA) on vascular cells. The γδ T cells and NK cells expressing NKG2D receptors recognize MICA on vascular smooth muscle cells and release perforin, resulting in acute vascular inflammation. Pro-inflammatory cytokines are released and increase the recruitment of mononuclear cells within the vascular wall. T cells infiltrate and recognize one or a few antigens presented by a shared epitope, which is associated with specific major Histocompatibility Complex alleles on the dendritic cells, these latter being activated through Toll-like receptors. Th1 lymphocytes drive the formation of giant cells through the production of interferon-γ, and activate macrophages with release of VEGF resulting in increased neovascularisation and PDGF, resulting in smooth muscle migration and intimal proliferation. Th17 cells induced by the IL-23 microenvironnement also contribute to vascular lesions through activation of infiltrating neutrophils. Although still controversial, dendritic cells may cooperate with B lymphocytes and trigger the production of anti-endothelial cell auto-antibodies resulting in complement-dependent cytotoxicity against endothelial cells. In a near future, novel drugs specifically designed to target some of the pathogenic mechanisms described above could be expanding the physician's therapeutic arsenal in Takayasu's arteritis. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855656     DOI: 10.1016/j.autrev.2011.08.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  68 in total

Review 1.  Renovascular hypertension--is it fibromuscular dysplasia or Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

2.  Vitamin D Levels in Takayasu's Arteritis and a Review of the Literature on Vasculitides.

Authors:  Fatma Alibaz-Oner; Özlem Asmaz-Haliloglu; Dilek Gogas-Yavuz; Meryem Can; Goncagul Haklar; Haner Direskeneli
Journal:  J Clin Lab Anal       Date:  2015-12-10       Impact factor: 2.352

Review 3.  Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.

Authors:  P I Novikov; I O Smitienko; S V Moiseev
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

Review 4.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

5.  Outcomes of different treatments on Takayasu's arteritis.

Authors:  Yu Xiao; Jian Zhou; Xiaolong Wei; Yudong Sun; Lei Zhang; Jiaxuan Feng; Rui Feng; Zhiqing Zhao; Zaiping Jing
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 6.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

Review 7.  Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review.

Authors:  Carlos Rodrigo Camara-Lemarroy; Jackeline Grace Lara-Campos; Eduardo Perez-Contreras; René Rodríguez-Gutiérrez; Dionicio Angel Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

8.  Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis.

Authors:  J P Dos Santos; R Artigiani Neto; C L P Mangueira; R Z Filippi; P S Gutierrez; J Westra; E Brouwer; A W S de Souza
Journal:  Clin Exp Immunol       Date:  2020-07-30       Impact factor: 4.330

9.  IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.

Authors:  Li-Li Pan; Juan Du; Na Gao; Hua Liao; Jin Wan; Wei-Ping Ci; Chun Yang; Tian Wang
Journal:  Clin Rheumatol       Date:  2016-09-15       Impact factor: 2.980

Review 10.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.